No video visit
All states
GLP-1 weight loss in Maryland
- Visit type
- No video visit required
- Licensing
- Maryland Board of Physicians
- Updated
- Licensed by
- Maryland Board of Physicians
- Telehealth
- No video visit required
- Semaglutide injections
- Available
- Tirzepatide injections
- Available
- Medicaid
- Not covered for weight loss
- Shipping
- 2–3 business days
Maryland residents can now access GLP-1 medications like semaglutide and tirzepatide through telehealth — from Baltimore and the D.C. suburbs to Frederick, Annapolis, and the Eastern Shore. Pallas Health connects you with a board-certified provider licensed in Maryland who reviews your intake — by secure message in most cases — and, if appropriate, prescribes medication that ships to any Maryland address in a few business days.
How telehealth prescribing works in Maryland
Maryland permits licensed providers to establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s through telehealth — including asynchronous review of your intake — when the standard of care is met.
Maryland requires any provider prescribing to a Maryland resident to hold an active Maryland medical license. Under Maryland Board of Physicians telehealth regulations, a licensed provider may establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s through telehealth, including synchronous video and, in appropriate cases, asynchronous review adequate to establish diagnoses and identify contraindications, provided the standard of care is met. Maryland is a member of the Interstate Medical Licensure Compact (IMLC), which streamlines licensing for qualifying out-of-state providers, but does not waive the Maryland-license requirement. Every Pallas clinician who treats Maryland patients is individually licensed in Maryland; depending on your history, a provider may follow up by message, video, or request additional labs before prescribing. GLP-1s are not controlled substances, so Maryland's separate Prescription Drug Monitoring Program and controlled-substance telemedicine requirements don't add friction here, but our providers still document a complete history, screen for contraindications like personal or family history of medullary thyroid carcinoma, and schedule follow-up visits to monitor response and titrate the dose.
Medicaid & insurance in Maryland
Maryland Medicaid does not currently cover GLP-1 medications for weight loss for most enrollees. Wegovy is covered for Medicaid participants who are overweight or obese and have cardiovascular disease, or for adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis. Zepbound is covered for obese adults with obstructive sleep apnea. Pending legislation (SB 496) could expand broader obesity-indication coverage starting July 2026. Compounded GLP-1s are not covered. Pallas is a cash-pay service, so Medicaid rules do not affect our pricing. Pallas is a cash-pay telehealth service. Medicaid and private insurance do not apply to our prescriptions; pricing is flat and disclosed up front.
Simple cash-pay pricing in Maryland
No insurance, and the same price in every Maryland ZIP code. You see your full price during intake, before you pay anything. One plan price covers your US-licensed provider, check-ins, dose adjustments and care-team messaging, with no membership fee. Medication ships free, and nothing is charged until a clinician prescribes. Cancel anytime. Your clinician helps determine which option is appropriate for you.
Compounded
- Semaglutide injectionsFrom $139
- Tirzepatide injectionsFrom $179
Brand-name
- Wegovy® injectionsFrom $499
- Zepbound® injectionsFrom $499
- Ozempic® injectionsFrom $499
- Mounjaro® injections$1,099/mo
- Wegovy® pillFrom $299
- Foundayo™ pillFrom $299
Semaglutide vs tirzepatide in Maryland
Both are once-weekly injections available to Maryland patients through Pallas, as compounded preparations and as the FDA-approved brand-name products. They work differently: semaglutide activates the GLP-1 receptor, while tirzepatide activates both the GLP-1 and GIP receptors — two of the gut hormones that regulate appetite and fullness.
In SURMOUNT-5, the head-to-head clinical trial of the FDA-approved products, Zepbound® (tirzepatide 10 mg or 15 mg weekly) produced greater average weight loss than Wegovy® (semaglutide 1.7 mg or 2.4 mg weekly) — 20.2% versus 13.7% of body weight over 72 weeks — with broadly similar tolerability. That trial predates Wegovy®'s higher 7.2 mg weekly dose, which reached 18.7% average weight loss over 72 weeks in the separate STEP UP trial; separate trials do not provide a direct comparison. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.
Cost and track record differ too: compounded semaglutide renews at $199 every 4 weeks versus $299 for tirzepatide (full terms in the questions below), and semaglutide has the longer post-market record. Which medication fits your health history, goals, and budget is a decision you make with a clinician licensed in Maryland — our full semaglutide vs tirzepatide comparison covers the deeper differences.
Cities served in Maryland
Partner pharmacies ship to every ZIP code in Maryland, including:
- Baltimore
- Frederick
- Rockville
- Gaithersburg
- Silver Spring
- Columbia
- Annapolis
- Bethesda
Maryland GLP-1 questions
No. Maryland allows a licensed clinician to review your intake by secure message and prescribe without a scheduled video call. They may ask for a video visit only if your history calls for it.
Start the online intake (about 5 minutes). A Maryland-licensed clinician reviews it by secure message, and if a GLP-1 is appropriate, a US-licensed pharmacy ships it to you in 2–3 business days.
Yes. A Maryland-licensed clinician can prescribe it for you with a documented clinical reason, and a US-licensed compounding pharmacy prepares it per patient. Brand-name Wegovy® is also available.
Same intake as semaglutide. If appropriate, a Maryland-licensed clinician can prescribe compounded tirzepatide or FDA-approved Zepbound® or Mounjaro®, and explains which fits you.
Yes. Maryland nurse practitioners prescribe independently, with no physician agreement required. GLP-1s are not controlled substances, so they can be prescribed by telehealth.
Several do. Check that its clinicians are licensed in Maryland, that it uses US-licensed compounding pharmacies, and that it is LegitScript-certified. Pallas serves Maryland.
Intake takes about 5 minutes, and a Maryland-licensed clinician usually reviews it within 1 to 2 business days. If prescribed, the pharmacy ships in 2–3 business days.
Yes. Partner pharmacies ship to every Maryland ZIP code, from Baltimore and Frederick to the smallest towns, usually in 2–3 business days. Remote addresses may take an extra day.
Several do. Check that its clinicians hold a Maryland license, that it uses US-licensed pharmacies, and that it is LegitScript-certified (the database is public). Pallas serves Maryland.
Not for weight loss generally — Wegovy® is covered with heart disease or a liver condition, Zepbound® for sleep apnea. Compounded GLP-1s aren't covered. Pallas is cash-pay; Medicaid rules don't apply.
One flat cash-pay price, the same in every Maryland ZIP code, no insurance needed. It covers your clinician, check-ins and messaging, and medication ships free once prescribed.
A Maryland-licensed clinician decides after reviewing your intake. GLP-1s are generally considered at a BMI of 30 or more, or 27 or more with a condition like high blood pressure.
Wegovy®, Ozempic®, Zepbound® and Mounjaro® are FDA-approved. Compounded semaglutide and tirzepatide are made per patient by US-licensed pharmacies and are not FDA-approved. Your clinician decides.
Yes. Tell your clinician your current medication, dose and everything else you take during intake. If appropriate, they continue you at a comparable dose. Don't change a prescription on your own.
Most patients use a once-weekly injection with a very fine needle. A daily tablet is available on request. Your clinician confirms which form is appropriate for you.
Mostly stomach-related: nausea, constipation or diarrhea, usually mildest when the dose is raised slowly. They are avoided in pregnancy and with a personal or family history of medullary thyroid cancer or MEN2.
You answer health questions online in about 5 minutes. A Maryland-licensed clinician reviews it by secure message, and if a GLP-1 is appropriate, a licensed pharmacy ships it in 2–3 business days.
Yes — refills renew on a set schedule so they arrive before you run out. Your first order ships in 2–3 business days and most patients start low and step up gradually; change or cancel anytime in the portal.
Compounded semaglutide injections are $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Your clinician, check-ins and messaging are included; shipping is free.
Compounded tirzepatide injections are $179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Your clinician, check-ins and messaging are included; shipping is free.
Yes. Wegovy®, Zepbound® and Foundayo™ are FDA-approved for weight management, Ozempic® and Mounjaro® for type 2 diabetes. All are cash-pay: pens from $499 first month, daily pills from $299.
Maryland Medicaid does not currently cover GLP-1 medications for weight loss for most enrollees. Compounded GLP-1s are not covered. Pallas is cash-pay, so Medicaid rules do not apply.
Two cash-pay paths: stay on Wegovy® or Zepbound® from $499 first month, or a compounded plan from $139 first month if a licensed clinician finds it appropriate. Tell your clinician your current dose.
A decision for you and your clinician. Semaglutide costs less and has the longer track record; tirzepatide acts on two gut-hormone receptors instead of one. The comparison above covers the trials.
Pallas serves all of Maryland with one price for compounded semaglutide: $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. No video visit is required.
Rule changes affecting Maryland
No rule changes affecting Maryland since this tracker began on May 29, 2026; the requirements shown here have held steady over that period.
From our state-by-state rules tracker. Get an email when a rule changes.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.